Scale -


  • Revenue is 3739 Rs Cr; Continuous Growth over 3 years; in Top Quartile
  • Ebitda is 989 Rs Cr; in Top Quartile
  • PAT is 317 Rs Cr; in Top Quartile; Annual Decline is -36 %; Continuous Decline over 3 years
  • Quarterly Revenue is 736 Rs Cr; in Top Quartile
  • PBT is -19.2 Rs Cr; Annual Decline is -38 %; in Bottom Quartile
  • Quarterly Profit is -9 Rs Cr; in Bottom Quartile

Profitability -


  • PBDIT Margin is 26.45 %; Annual Decline is -13 %; Continuous Decline over 3 years
  • PAT Margin is 8.47 %; Annual Decline is -38 %; Continuous Decline over 3 years; 5 Year CAGR is -14 %
  • Quarterly Ebitda Margin is 12 %; in Bottom Quartile
  • Quarterly Profit margin is -1 %; in Bottom Quartile

Return -


  • ROCE is 9.74 %; Annual Decline is -23 %; Continuous Decline over 3 years
  • ROA is 4.48 %; Annual Decline is -39 %; Continuous Decline over 3 years
  • ROE is 6.54 %; Annual Decline is -38 %; Continuous Decline over 3 years
  • Asset Turnover is 54 %; Continuous Decline over 3 years

Efficiency -


  • Inventory Turnover Ratio is 25.19; Annual Growth is 36 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 41 %
  • Operating cash flow is 915 Rs Cr; in Top Quartile
  • Current Ratio is 1.38; Continuous Decline over 3 years

Solvancy -


  • Debt/Equity is 0; Annual Decline is -100 %
  • Total Debt is 9.4 Rs Cr; Annual Decline is -92 %; Continuous Decline over 3 years; 5 Year CAGR is -67 %
  • Contingent Liabilities is 590 Rs Cr; Continuous Decline over 3 years; in Top Quartile

Quality -


  • Operating cashflow/PAT is 289 %; Annual Growth is 23 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 18 %
  • Exceptional Items/PBT is -19 %; Annual Decline is -484 %; in Bottom Quartile
  • Change in Inventories/Total Expenses is 0 %; Annual Decline is -60 %; Continuous Decline over 3 years; in Top Quartile
  • Operating cashflow/ebitda is 93 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Analyst Estimates: Here's What Brokers Think Of Syngene International Limited (NSE:SYNGENE) After Its Second-Quarter Report
stock insights biocon share recovery syngene q2 results impact
Syngene International Ltd Surges on High-Value Trading Amid Institutional Interest
Syngene International Q2 FY27 Results Newspaper Publication
Syngene Q2FY27 Results: Net profit ?322 crore misses estimates
Earnings call transcript: Syngene Q2 2026 profit miss offsets revenue beat By Investing.com
Piramal Pharma, United Breweries, Syngene shares surge amid spike in volumes; check full list
Ramky Infrastructure, Aarti Drugs and Syngene Lead Volume Gainers
Syngene International (NSE:SYNGENE) Q2 FY27 Results and Business Update
Syngene International Ltd Faces Bearish Momentum Amid Technical Downturn
Syngene International Ltd Sees Exceptional Volume Surge Amid Strong Sell Rating
Syngene International Ltd Shows Mixed Technical Signals Amid Prolonged Downtrend
Syngene International Share Price
Syngene International shares surge 12%, biggest 1-day gain in 6 years; what drove the rally despite a Q2 profit drop?
Syngene Q2 FY27 slides show margin recovery, strategic repositioning By Investing.com
Syngene Q2 Profit Falls 52% To ?32 Crore As Lower Zoetis Revenue, Forex Losses Hit Margins
Syngene reports sequential revenue growth of 13% in Q2 FY27
Syngene International (NSEI:SYNGENE)
Syngene International CFO and Strategy Head Resign; Management Restructuring Announced
Syngene International CFO Deepak Jain to resign; SMP designations change
Syngene International Q2 Results: Net profit tanks 52% on lower Zoetis revenue, forex hedge losses
Syngene Posts 13% Sequential Revenue Growth in Q2 FY27, Signs First Manufacturing Deal for US Bayview Biologics Plant
Syngene Q2 Profit: Rs 32.2 Cr, Rebounds from Q1 Loss
Syngene Reports Q2 Revenue of ?833 Crore Versus ?910 Crore YoY
Syngene International (BSE:539268)
SYNGENE Outlook for the Week
Syngene International Share Price News After 5.43% Drop